Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke "MINOS"

Completed

Phase 1/2 Results

Summary of Purpose

The primary aim of this study is to find out which of 4 different doses of minocycline are safe and well tolerated so that we will know the optimal dose to test in future patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 December 2011.

1 May 2008 28 Feb 2008 1 Jan 2010 1 Jan 2010 1 Dec 2011 1 Aug 2011
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment

Contacts